Clinical trial
A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to…
NCT00089947 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00089947 |
|---|---|
| Title | A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection |
| Official title | Randomized, Prospective, Phase 2 Study Comparing Thymoglobulin in a Rapid Discontinuation of Corticosteroids Protocol With Standard Corticosteroid Therapy in Living Donor Renal Transplantation Using Mycophenolate Mofetil and Tacrolimus Maintenance Therapy |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplantation, Graft Rejection |
| Intervention type | Drug |
| Interventions | Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)] |
| Enrollment | 150 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 20, 2004 |
| Last update posted | Mar 18, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: